Is the combination of Hirschsprung disease, non‑classic congenital adrenal hyperplasia, arthrochalasia‑type Ehlers‑Danlos syndrome, and intense friendliness best explained by a single genetic syndrome?

No Single Genetic Syndrome Explains This Combination

The constellation of Hirschsprung disease, non-classic congenital adrenal hyperplasia (NCCAH), arthrochalasia-type Ehlers-Danlos syndrome (aEDS), and intense friendliness does not represent a recognized single genetic syndrome and instead reflects multiple distinct genetic conditions occurring together.

Why These Are Separate Entities

Distinct Genetic Mechanisms

Each condition has its own well-defined genetic basis:

• Hirschsprung disease involves multiple susceptibility genes (primarily RET and EDNRB pathways) with complex inheritance patterns 1. While it associates with chromosomal syndromes like Down syndrome (5% of cases) and 22q11.2 deletion syndrome, these don't include the other features mentioned 2, 1.

• NCCAH results from autosomal recessive mutations in CYP21A2 on chromosome 6p21.3, causing 21-hydroxylase deficiency 3. This is completely separate from Hirschsprung genetics.

• Arthrochalasia EDS stems from autosomal dominant variants in COL1A1 or COL1A2 (rarely autosomal recessive), causing defective type I collagen 4, 5. This has no genetic overlap with either Hirschsprung or NCCAH.

• Intense friendliness as a behavioral phenotype is characteristic of Williams-Beuren syndrome (7q11.23 deletion including ELN gene) 6, which is genetically unrelated to the other three conditions.

The CAH-X Connection: A Partial Overlap

There is one documented genetic overlap worth noting: A contiguous deletion of CYP21A2 extending into the adjacent TNXB gene creates "CAH-X syndrome," found in 7% of CAH patients 7. This causes:

• Classic or non-classic CAH (from CYP21A2 deletion)
• Tenascin-X haploinsufficiency leading to hypermobile EDS features (not arthrochalasia type)

However, this explains only 2 of the 4 features and involves hypermobile EDS, not arthrochalasia EDS 8, 7.

Clinical Implications

Evaluation Strategy

When encountering this combination:

1. Confirm each diagnosis independently with appropriate genetic testing:

   • Hirschsprung: RET gene analysis, rectal biopsy
   • NCCAH: ACTH stimulation test, CYP21A2 sequencing
   • Arthrochalasia EDS: COL1A1/COL1A2 sequencing, skin biopsy for collagen studies
   • Behavioral phenotype: Consider chromosomal microarray for 7q11.23 deletion

2. Screen for known syndromic associations of each condition separately 9:

   • Hirschsprung: Evaluate for Down syndrome, 22q11.2 deletion, Waardenburg syndrome
   • Look for dysmorphic features, developmental delay, or additional congenital anomalies

3. Consider chromosomal microarray as first-tier testing given multiple congenital anomalies, as this may reveal cryptic deletions or duplications affecting multiple loci 9.

Important Caveats

• Coincidental occurrence of multiple rare genetic conditions in one individual, while statistically unlikely, does occur
• Consanguinity increases risk of multiple autosomal recessive conditions
• Unrecognized contiguous gene syndromes remain possible but would require advanced genomic analysis
• The combination suggests the need for comprehensive genetic evaluation including whole exome or genome sequencing to identify potential novel associations

Management Priorities

Each condition requires independent management focused on preventing morbidity and mortality:

• Hirschsprung: Surgical intervention to prevent enterocolitis and toxic megacolon
• NCCAH: Monitor for metabolic complications, treat symptomatic hyperandrogenism 3
• Arthrochalasia EDS: Prevent joint dislocations, monitor for scoliosis, avoid contact sports 4
• Behavioral phenotype: Appropriate developmental and social support

The absence of a unifying diagnosis does not diminish the importance of addressing each condition's specific risks to optimize quality of life and prevent serious complications.